Potency and tolerance of calcitonin stimulation with high-dose calcium versus pentagastrin in normal adults

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 8, 2009, Pages 2970-2974

  Doyle, Patricia ^a   Düren, Christian ^a   Nerlich, Kai ^a   Verburg, Frederik A ^a   Grelle, Inge ^a   Jahn, Hanne ^a   Fassnacht, Martin ^a   Mäder, Uwe ^a   Reiners, Christoph ^a   Luster, Markus ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; CALCIUM; PENTAGASTRIN;

ADULT; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; IMMUNOASSAY; MALE; MEASUREMENT; NORMAL HUMAN; PRIORITY JOURNAL; STIMULATION;

EID: 68549110229     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-2403     Document Type: Article

References (20)

1. Hahm JR, Lee MS, Min YK, Lee MK, Kim KW, Nam SJ, Yang JH, Chung JH 2001 Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases. Thyroid 11:73-80
2. Elisei R, Bottici V, Luchetti F, Di Coscio G, Romei C, Grasso L, Miccoli P, Iacconi P, Basolo F, Pinchera A, Pacini F 2004 Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab 89:163-168
3. Costante G, Meringolo D, Durante C, Bianchi D, Nocera M, Tumino S, Crocetti U, Attard M, Maranghi M, Torlontano M, Filetti S 2007 Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab 92:450-455
4. Machens A, Hauptmann S, Dralle H 2008 Medullary thyroid cancer responsiveness to pentagastrin stimulation: an early surrogate parameter of tumor dissemination? J Clin Endocrinol Metab 93:2234-2238
5. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W 2006 European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787-803
6. Demers LM, Spencer CA 2003 Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Clin Endocrinol (Oxf) 58:138-140
7. Karanikas G, Moameni A, Poetzi C, Zettinig G, Kaserer K, Bieglmayer C, Niederle B, Dudczak R, Pirich C 2004 Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects. J Clin Endocrinol Metab 89:515-519
8. Vierhapper H, Niederle B, Bieglmayer C, Kaserer K, Baumgartner-Parzer S 2005 Early diagnosis and curative therapy of medullary thyroid carcinoma by routine measurement of serum calcitonin in patients with thyroid disorders. Thyroid 15:1267-1272
9. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI, Tuttle RM 2006 Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109-142
10. Cheung K, Roman SA, Wang TS, Walker HD, Sosa JA 2008 Calcitonin measurement in the evaluation of thyroid nodules in the United States: a cost-effectiveness and decision analysis. J Clin Endocrinol Metab 93:2173-2180
11. Wion-Barbot N, Schuffenecker I, Niccoli P, Conte-Devolx B, Lecomte P, Houdent C, Bigorgne JC, Modigliani E 1997 Results of the calcitonin stimulation test in normal volunteers compared with genetically unaffected members of MEN 2A and familial medullary thyroid carcinoma families. Ann Endocrinol (Paris) 58:302-308
12. Hodak SP, Burman KD 2004 The calcitonin conundrum - is it time for routine measurement of serum calcitonin in patients with thyroid nodules? J Clin Endocrinol Metab 89:511-514
13. Wells Jr SA, Baylin SB, Linehan WM, Farrell RE, Cox EB, Cooper CW 1978 Provocative agents and the diagnosis of medullary carcinoma of the thyroid gland. Ann Surg 188:139-141
14. Gharib H, Kao PC, Heath 3rd H 1987 Determination of silica-purified plasma calcitonin for the detection and management of medullary thyroid carcinoma: comparison of two provocative tests. Mayo Clin Proc 62:373-378.
15. Gimm O, Sutter T, Dralle H 2001 Diagnosis and therapy of sporadic and familial medullary thyroid carcinoma. J Cancer Res Clin Oncol 127:156-165
16. Bieglmayer C, Vierhapper H, Dudczak R, Niederle B 2007 Measurement of calcitonin by immunoassay analyzers. Clin Chem Lab Med 45:662-666
17. Leboulleux S, Baudin E, Travagli JP, Schlumberger M 2004 Medullary thyroid carcinoma. Clin Endocrinol (Oxf) 61:299-310
18. Vitale G, Ciccarelli A, Caraglia M, Galderisi M, Rossi R, Del Prete S, Abbruzzese A, Lupoli G 2002 Comparison of two provocative tests for calcitonin in medullary thyroid carcinoma: omeprazole vs pentagastrin. Clin Chem 48:1505-1510
19. d'Herbomez M, Caron P, Bauters C, Cao CD, Schlienger JL, Sapin R, Baldet L, Carnaille B, Wemeau JL 2007 Reference range of serum calcitonin levels in humans: influence of calcitonin assays, sex, age, and cigarette smoking. Eur J Endocrinol 157:749-755
20. Guyetant S, Rousselet MC, Durigon M, Chappard D, Franc B, Guerin O, Saint-Andre JP 1997 Sex-related C cell hyperplasia in the normal human thyroid: a quantitative autopsy study. J Clin Endocrinol Metab 82:42-47